World's Best Scientists 2026 revealed!
VIEW LIST
Christopher E.M. Griffiths

Christopher E.M. Griffiths

University of Manchester
United Kingdom

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 139 1749 1624 179 171 805 77122

Christopher E.M. Griffiths publications per year

The chart shows the history of publications by Christopher E.M. Griffiths between 1985 and 2021, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Christopher E.M. Griffiths published across 37 years, from 1985 to 2021, averaging 21.9 papers a year. Output peaked at 56 publications in 2021. 107 of the 810 publications appeared in the last two years.

No. of publications
10 20 30 40 50
Bar chart. Horizontal axis: year, 1985 to 2021. Vertical axis: number of publications, 0 to 56. Peak 56 publications in 2021. 1985: 1 publication 1986: 4 publications 1987: 5 publications 1988: 2 publications 1989: 5 publications 1990: 16 publications 1991: 10 publications 1992: 15 publications 1993: 13 publications 1994: 8 publications 1995: 11 publications 1996: 5 publications 1997: 8 publications 1998: 14 publications 1999: 5 publications 2000: 16 publications 2001: 28 publications 2002: 24 publications 2003: 17 publications 2004: 25 publications 2005: 34 publications 2006: 28 publications 2007: 25 publications 2008: 28 publications 2009: 31 publications 2010: 22 publications 2011: 13 publications 2012: 28 publications 2013: 31 publications 2014: 38 publications 2015: 42 publications 2016: 36 publications 2017: 39 publications 2018: 42 publications 2019: 34 publications 2020: 51 publications 2021: 56 publications
1985 2021

810 publications in total across all disciplines

View publications per year as a table
Christopher E.M. Griffiths: publications per year, 1985 to 2021
Year Publications
1985 1
1986 4
1987 5
1988 2
1989 5
1990 16
1991 10
1992 15
1993 13
1994 8
1995 11
1996 5
1997 8
1998 14
1999 5
2000 16
2001 28
2002 24
2003 17
2004 25
2005 34
2006 28
2007 25
2008 28
2009 31
2010 22
2011 13
2012 28
2013 31
2014 38
2015 42
2016 36
2017 39
2018 42
2019 34
2020 51
2021 56
Total 810
Download as CSV

Christopher E.M. Griffiths publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Christopher E.M. Griffiths sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 801–820 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 805 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204 805
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Christopher E.M. Griffiths D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Christopher E.M. Griffiths sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 138–139 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 139 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134 139
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Research.com Recognitions

  • 2015 - Member of Academia Europaea

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Gene

His primary areas of investigation include Psoriasis, Internal medicine, Dermatology, Immunology and Surgery. Christopher E.M. Griffiths combines subjects such as Quality of life and Disease with his study of Psoriasis. His Internal medicine research incorporates elements of Gastroenterology, Placebo and Endocrinology.

Tretinoin and Negroid is closely connected to Chemotherapy in his research, which is encompassed under the umbrella topic of Dermatology. His studies in Surgery integrate themes in fields like Cohort study, Confidence interval and Ustekinumab. His study in Guselkumab is interdisciplinary in nature, drawing from both Etanercept and Risankizumab.

His most cited work include:

  • Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence (1192 citations)
  • Secukinumab in plaque psoriasis--results of two phase 3 trials. (1146 citations)
  • Pathogenesis and clinical features of psoriasis. (1130 citations)

What are the main themes of his work throughout his whole career to date?

Psoriasis, Internal medicine, Dermatology, Immunology and Pathology are his primary areas of study. His study in Psoriasis focuses on Psoriasis Area and Severity Index in particular. His Psoriasis Area and Severity Index research is multidisciplinary, relying on both Dermatology Life Quality Index, Adverse effect and Severity of illness.

His Internal medicine study integrates concerns from other disciplines, such as Placebo, Endocrinology and Surgery. Christopher E.M. Griffiths works mostly in the field of Endocrinology, limiting it down to topics relating to Human skin and, in certain cases, Retinoic acid, as a part of the same area of interest. Christopher E.M. Griffiths has researched Dermatology in several fields, including Chemotherapy and MEDLINE.

He most often published in these fields:

  • Psoriasis (60.87%)
  • Internal medicine (29.12%)
  • Dermatology (23.45%)

What were the highlights of his more recent work (between 2018-2021)?

  • Psoriasis (60.87%)
  • Internal medicine (29.12%)
  • MEDLINE (8.83%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Psoriasis, Internal medicine, MEDLINE, Psoriasis Area and Severity Index and Dermatology. The study incorporates disciplines such as Clinical trial, Intensive care medicine, Disease, Etanercept and Cohort in addition to Psoriasis. He usually deals with Disease and limits it to topics linked to General partnership and Systematic review and Nursing.

His MEDLINE research incorporates themes from Global health, Physiology, Seasonality and Circadian rhythm. His Psoriasis Area and Severity Index study combines topics in areas such as Odds ratio, Dermatology Life Quality Index, Adverse effect and Dosing. In his study, Gastroenterology is strongly linked to Moderate to severe, which falls under the umbrella field of Dermatology.

Between 2018 and 2021, his most popular works were:

  • Clinical applications of machine learning algorithms: beyond the black box. (84 citations)
  • HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis (41 citations)
  • Clinical and genetic differences between pustular psoriasis subtypes (38 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Disease

His primary scientific interests are in Psoriasis, Internal medicine, Psoriasis Area and Severity Index, Cohort and Ustekinumab. His study deals with a combination of Psoriasis and Systemic therapy. Christopher E.M. Griffiths interconnects Dermatology Life Quality Index, Bioinformatics, Transcriptome, Randomized controlled trial and Confidence interval in the investigation of issues within Psoriasis Area and Severity Index.

He combines subjects such as Placebo and Interleukin 17 with his study of Randomized controlled trial. The study incorporates disciplines such as Dermatology, Acrodermatitis, Therapeutic drug monitoring and Cohort study in addition to Cohort. His work focuses on many connections between Ustekinumab and other disciplines, such as Clinical trial, that overlap with his field of interest in Propensity score matching and Number needed to treat.

Best Publications

  • Pathogenesis and clinical features of psoriasis.

    Christopher E. M. Griffiths;Jonathan N. W. N. Barker

  • Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence

    Rosa Parisi;Deborah P.M. Symmons;Christopher E.M. Griffiths;Darren M. Ashcroft

  • Secukinumab in plaque psoriasis--results of two phase 3 trials.

    Richard G. Langley;Boni E. Elewski;Mark Lebwohl;Kristian Reich

  • Psoriasis: epidemiology, clinical features, and quality of life

    R G B Langley;G G Krueger;C E M Griffiths

  • Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

    Andrew Blauvelt;Marjolein de Bruin-Weller;Melinda Gooderham;Jennifer C. Cather

  • Infliximab induction and maintenance therapy for moderate-to-severe psoriasis : a phase III, multicentre, double-blind trial

    Kristian Reich;Frank O Nestle;Kim Papp;Jean-Paul Ortonne

  • British guideline on the management of asthma: A national clinical guideline

    Graham Douglas;Bernard Higgins;Neil Barnes;Anne Boyter

  • Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity

    Lam C. Tsoi;Sarah L. Spain;Sarah L. Spain;Jo Knight;Eva Ellinghaus;Eva Ellinghaus

  • A Genome-Wide Association Study Identifies New Psoriasis Susceptibility Loci and an Interaction Between HLA-C and ERAP1

    Amy Strange;Francesca Capon;Chris C A Spencer

  • Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis

    Christopher E.M. Griffiths;Bruce E. Strober;Peter van de Kerkhof;Vincent Ho

  • Definition of treatment goals for moderate to severe psoriasis: a European consensus

    U. Mrowietz;K. Kragballe;K. Reich;P. Spuls

  • Keratinocytes as initiators of inflammation

    Jonathan N. W. N. Barker;C. E. M. Griffiths;Brian J. Nickoloff;R. S. Mitra

  • European S3-guidelines on the systemic treatment of psoriasis vulgaris

    D Pathirana;AD Ormerod;P Saiag;Catherine Smith

  • Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial

    Andrew Blauvelt;Kim A. Papp;Christopher E.M. Griffiths;Bruce Randazzo;Bruce Randazzo

  • A global phase III randomized controlled trial of etanercept in psoriasis : safety, efficacy, and effect of dose reduction

    Kim A. Papp;S. Tyring;M. Lahfa;J. Prinz

  • Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

    Christopher E M Griffiths;Kristian Reich;Mark Lebwohl;Peter van de Kerkhof

  • National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study

    Rosa Parisi;Ireny Y K Iskandar;Evangelos Kontopantelis;Matthias Augustin

  • Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial

    T N Brooklyn;M G S Dunnill;A Shetty;J J Bowden

  • Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)

    Kim Papp;Kristian Reich;Craig L. Leonardi;Leon Kircik

  • A genome-wide asociation study identifies new psoriasis susceptibility loci and an interaction betwEn HLA-C and ERAP1

    A. Strange;F. Capon;C. C. A. Spencer;J. Knight

Frequent Co-Authors

Jonathan Barker
Jonathan Barker King's College London
Catherine Smith
Catherine Smith King's College London
John J. Voorhees
John J. Voorhees University of Michigan–Ann Arbor
Helen L. Richards
Helen L. Richards University of Manchester
Dónal G. Fortune
Dónal G. Fortune University of Limerick
Jane Worthington
Jane Worthington University of Manchester
Kim Papp
Kim Papp Probity Medical Research
Ian Kimber
Ian Kimber University of Manchester
Ralf Paus
Ralf Paus University of Miami
Chris J. Main
Chris J. Main Keele University

External Links

Wikipedia of Christopher E.M. Griffiths Personal website of Christopher E.M. Griffiths

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Aspiring medical professionals benefit from exploring a range of online degrees and career pathways within healthcare. For those interested in the business and management side of medicine, healthcare administration degree programs offer flexible options to build skills in policy, leadership, and operations.

Nurses looking to advance their careers can consider adn to np bridge programs, providing accelerated pathways for experienced RNs to become nurse practitioners. These bridge programs can be especially valuable for those balancing work with further study.

For students interested in preventative care or wellness, earning an online nutrition degree opens doors to roles in dietetics, health education, and public health.

Individuals aiming for leadership roles in hospitals or health systems can pursue accredited mha programs. These Master of Health Administration programs, recognized for their quality standards, are ideal for those seeking to impact healthcare delivery at the organizational level.

Exploring these academic pathways online provides flexibility and a variety of options beyond the traditional MD, catering to evolving career goals in healthcare.

Best Scientists Citing Christopher E.M. Griffiths

Steven R. Feldman

Steven R. Feldman

Wake Forest University

Publications: 225

Alice B. Gottlieb

Alice B. Gottlieb

Icahn School of Medicine at Mount Sinai

Publications: 199

John J. Voorhees

John J. Voorhees

University of Michigan–Ann Arbor

Publications: 166

Mark Lebwohl

Mark Lebwohl

Icahn School of Medicine at Mount Sinai

Publications: 160

James T. Elder

James T. Elder

University of Michigan–Ann Arbor

Publications: 140

Kim Papp

Kim Papp

Probity Medical Research

Publications: 136

Ralf Paus

Ralf Paus

University of Miami

Publications: 126

Matthias Augustin

Matthias Augustin

Universität Hamburg

Publications: 125

Ulrich Mrowietz

Ulrich Mrowietz

Kiel University

Publications: 114

Alan Menter

Alan Menter

Texas A&M University

Publications: 113

James G. Krueger

James G. Krueger

Rockefeller University

Publications: 109

Gary J. Fisher

Gary J. Fisher

University of Michigan–Ann Arbor

Publications: 107

Carle Paul

Carle Paul

Federal University of Toulouse Midi-Pyrénées

Publications: 102

Jonathan Barker

Jonathan Barker

King's College London

Publications: 98

Lone Skov

Lone Skov

University of Copenhagen

Publications: 97

Giampiero Girolomoni

Giampiero Girolomoni

University of Verona

Publications: 96

Trending Scientists

Nicholas G. Martin

Nicholas G. Martin

QIMR Berghofer Medical Research Institute

Moniek Buijzen

Moniek Buijzen

Erasmus University Rotterdam

Ian S. Penton-Voak

Ian S. Penton-Voak

University of Bristol

Annette Cowie

Annette Cowie

University of New England

James E. Ayars

James E. Ayars

Agricultural Research Service

Kenichi Matsubara

Kenichi Matsubara

Osaka University

Jiri Lukas

Jiri Lukas

University of Copenhagen

Jungong Han

Jungong Han

Aberystwyth University

Alexandra Fedorova

Alexandra Fedorova

University of British Columbia

Bingsheng He

Bingsheng He

National University of Singapore

Asit Baran Panda

Asit Baran Panda

Academy of Scientific and Innovative Research

Charles T. Campbell

Charles T. Campbell

University of Washington

Rick A. Nishimura

Rick A. Nishimura

Mayo Clinic

Thomas T. Veblen

Thomas T. Veblen

University of Colorado Boulder

Alice C. Hughes

Alice C. Hughes

University of Melbourne

Ding Zhou

Ding Zhou

Nanjing Tech University

Related Medicine Rankings & Guides

2027 Best Online DNP Programs

2027 Best Online DNP Programs
2027 Best Online Surgical Tech Certificate Programs

2027 Best Online Surgical Tech Certificate Programs
2027 Easiest Nurse Practitioner Specialty Programs to Get Into

2027 Easiest Nurse Practitioner Specialty Programs to Get Into
2027 Best Online Medical & Healthcare Certificate Programs

2027 Best Online Medical & Healthcare Certificate Programs
2027 Easiest DNP Programs

2027 Easiest DNP Programs
2027 Easiest RN-to-MSN Online Programs to Get Into

2027 Easiest RN-to-MSN Online Programs to Get Into
September 2027 Best Online Kinesiology Programs

September 2027 Best Online Kinesiology Programs
2027 Most Affordable Online Accelerated BSN Programs for Non-Nurses

2027 Most Affordable Online Accelerated BSN Programs for Non-Nurses
2027 Best Nurse Practitioner Programs in Texas – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Texas – Accredited Schools Online & Campus
2027 Best Online BSN to FNP Programs

2027 Best Online BSN to FNP Programs
2027 Most Affordable Online LPN to RN Degree Programs

2027 Most Affordable Online LPN to RN Degree Programs
2027 Best Online Nursing Programs in Florida – Accredited RN to BSN Programs

2027 Best Online Nursing Programs in Florida – Accredited RN to BSN Programs
2027 Best Nurse Practitioner Programs in Utah – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Utah – Accredited Schools Online & Campus
2027 Fastest Online Nutrition Degree Programs

2027 Fastest Online Nutrition Degree Programs
2027 Most Affordable Online Accelerated Nursing Programs With High Graduation Rate

2027 Most Affordable Online Accelerated Nursing Programs With High Graduation Rate
2027 Best Nurse Practitioner Programs in Maryland – Accredited Schools Online & Campus

2027 Best Nurse Practitioner Programs in Maryland – Accredited Schools Online & Campus
2027 Fastest Online MSN in Forensic Nursing Programs

2027 Fastest Online MSN in Forensic Nursing Programs
2027 Most Affordable Online Medical Billing and Coding Courses

2027 Most Affordable Online Medical Billing and Coding Courses
2027 Easiest Nurse Practitioner Degree Programs

2027 Easiest Nurse Practitioner Degree Programs
2027 Most Affordable CNA to RN Online Bridge Programs

2027 Most Affordable CNA to RN Online Bridge Programs
2027 Most Affordable LVN to RN Online Bridge Programs

2027 Most Affordable LVN to RN Online Bridge Programs

Recently Published Articles

2027 How to Become a Nurse Practitioner in Iowa

2027 How to Become a Nurse Practitioner in Iowa
2027 What Happens If an Addiction Counseling Degree Master's Program Doesn't Meet Licensure Rules?

2027 What Happens If an Addiction Counseling Degree Master's Program Doesn't Meet Licensure Rules?
2027 Is Media Communication a Hard Major? What Students Should Know

2027 Is Media Communication a Hard Major? What Students Should Know
2027 Online Applied Psychology Doctorate Programs with Specializations: Concentrations, Tracks, and Career Paths

2027 Online Applied Psychology Doctorate Programs with Specializations: Concentrations, Tracks, and Career Paths
2027 Easiest Online Occupational Therapy Master's Degree Programs That Pay Well: High-Salary Degrees with Simple Admissions

2027 Easiest Online Occupational Therapy Master's Degree Programs That Pay Well: High-Salary Degrees with Simple Admissions
2027 What Can You Do With a Master’s in Public Relations?

2027 What Can You Do With a Master’s in Public Relations?
2027 Accredited Online Health Information Management Degree Programs With No GRE or GMAT Requirements

2027 Accredited Online Health Information Management Degree Programs With No GRE or GMAT Requirements
2027 How to Become a Licensed Therapist (LPC) in Orlando, FL: Counselor License Requirements

2027 How to Become a Licensed Therapist (LPC) in Orlando, FL: Counselor License Requirements
2027 Best Online Nursing Leadership Doctorate Programs for Consulting Careers

2027 Best Online Nursing Leadership Doctorate Programs for Consulting Careers
2027 Most Flexible Careers You Can Pursue With a Biotechnology Degree: Remote, Hybrid, and Freelance Paths

2027 Most Flexible Careers You Can Pursue With a Biotechnology Degree: Remote, Hybrid, and Freelance Paths
2027 Online Counselor Education Degree Programs for Veterans: GI Bill Benefits, Costs & Top Considerations

2027 Online Counselor Education Degree Programs for Veterans: GI Bill Benefits, Costs & Top Considerations
2027 Online Sports Psychology Bachelor's Degree Programs With No Prerequisites

2027 Online Sports Psychology Bachelor's Degree Programs With No Prerequisites
2027 What Does a DNP Do? Roles & Responsibilities

2027 What Does a DNP Do? Roles & Responsibilities
2027 How to Become a School Nurse – Salary & Requirements

2027 How to Become a School Nurse – Salary & Requirements
2027 Online Nursing Education Degree Programs With No Personal Statement or Admissions Essay Required

2027 Online Nursing Education Degree Programs With No Personal Statement or Admissions Essay Required
2027 How to Become a Medical Biller & Coder in Colorado Springs, CO: Education Requirements & Certification

2027 How to Become a Medical Biller & Coder in Colorado Springs, CO: Education Requirements & Certification
2027 Online SLP Programs Without Campus Visits: What to Expect

2027 Online SLP Programs Without Campus Visits: What to Expect
2027 How To Become an Economist: Salary & Career Paths

2027 How To Become an Economist: Salary & Career Paths
2027 No-Exam Online Accounting Master's Degrees: Schools, Costs & Outcomes

2027 No-Exam Online Accounting Master's Degrees: Schools, Costs & Outcomes
2027 How to Become a Substitute Teacher in Nebraska

2027 How to Become a Substitute Teacher in Nebraska
2027 Fastest Accredited Online Christian Ministry Programs: Accelerated Degrees and Completion Times

2027 Fastest Accredited Online Christian Ministry Programs: Accelerated Degrees and Completion Times